Purdue Pharma “misrepresented” impact of OxyContin, former sales rep says

June 21, 2018

Purdue Pharma, the maker of OxyContin, admitted to falsley claiming the drug was less addictive than other opioids. But a former salesperson says the company’s questionable practices did not end there. CBS News correspondent Tony Dokoupil reports.

Read Full Article

November 29, 2022
The chase is on: Regulators are slowly cracking down on vapes aimed at teens
November 7, 2022
Record $1.9B Powerball jackpot a hazard for those with gambling addiction
October 21, 2022
Health department medical detectives find 84% of U.S. maternal deaths are preventable
October 11, 2022
Untreated & Unheard: The Addiction Crisis in America
October 9, 2022
How Erin French found herself at The Lost Kitchen
October 5, 2022
U.S. starts fiscal year with record $31 trillion in debt